About Us
Mercy Health Saint Mary's and Hauenstein Neurosciences is an integrated network of health care excellence offering a unique combination of capabilities to deliver a health care experience that is complete and personally satisfying. Saint Mary's is a member of Trinity Health, the country's fourth-largest Catholic health care system. Our commitment to offer highly skilled patient care in a holistic and patientcentered environment has made us a progressive leader in West Michigan. Our network encompasses more than five community outreach centers and we have affiliations with home health care, rehabilitation services, and the area's premier primary care network, Advantage Health Physician Network. These capabilities allow us to engage patients and their caregivers in the performance and evaluation of the proposed study.
-
Contact: Muhammad Umar Farooq
Job Title: Medical Director, Division of Stroke/Vascular Neurology and Neurohospitalist Service
Address:
Hauenstein Neuroscience Center Mercy Health Saint Mary's
220 Cherry Street SE
Grand Rapids, MI 49503
Phone: 616-685-6455
Fax: 616-685-4351
Email: farooqmu@mercyhealth.com
Other Contact:
Dr. Philip B. Gorelick, MD, MPH
E-mail: pgorelic@mercyhealth.com
Phone: 616-685-6455 -
My training background gives me extensive experience in the clinical management of patients with stroke. I am board certified by the American Board of Psychiatry and Neurology in both clinical Neurology and Vascular neurology. In my role as the Stroke director at Hauenstein Neuroscience Center, Grand Rapids, Michigan I am actively participating in the care of such patients every day and coordinate their care with primary care physicians. We have primary stroke center certification through the Joint Commission. We provide comprehensive stroke care care and serving as a tertiary care referral center in West Michigan.
We are actively involved in the clinical research. Our stroke team is working on several research projects including the use of SyphagmoCor in stroke prevention and the use of iPAD technology in stroke patients with aphasia and severe dysarthria. We are also participating in other various NIH and industry sponsored trials such as POINT, MILE STONE study and RESPECT ESUS trial. Our stroke program is a part of NIH StrokeNet in collaboration with the University of Michigan.